HAEMATO-BIOCHEMCIAL STUDIES OF NANOPARTICLE-BASED VACCINE AGAINST R2B STRAIN OF NEW CASTLE DISEASE IN CHICKS
DOI:
https://doi.org/10.22159/ijpps.2024v16i3.49956Keywords:
Pre-challenged, Post-challenged, R2B virus, Copper oxide nanoparticleAbstract
Objective: The goal of the current study is to create a Newcastle disease vaccine based on green synthesised metal oxide nanoparticles and to study the haematological and biochemical effects of this vaccine in chicks.
Methods: Copper Oxide Nanoparticles (CuONPs) from Momordica charantia were synthesised biologically. These copper oxide nanoparticles were combined with a commercially available freeze-dried Newcastle Di0sease (ND) vaccination of the live R2B strain to use it as a vaccine delivery method in the current work. Haematological and biochemical parameters were investigated in pre-challenged and post-challenged chicks.
Results: After the injection of copper nanoparticles-based vaccines, it was found that the pre-challenged animals and post challeneged animals showed highly significant difference (P<0.05) in their total White Blood Cells (WBC) counts, hemoglobin concentration, hematocrit value, and Erythrocyte Sedimentation Rate (ESR) in comparison to control and live vaccinated groups. It was also investigated that for biochemical parameters After the injection of copper nanoparticles-based vaccines, both pre-challenged animals and post challeneged animals showed highly significant difference (P<0.05) in their blood glucose level, serum total protein, creatinine, serum alkaline phosphatase, Aspartate Amino Transferase (ALT) and Alanine Amino Transferasse (AST) in comparison to control and live vaccinated groups.
Conclusion: The vaccine not only makes chicks healthier, but also shields them from the virus that causes Newcastle disease
Downloads
References
James WD, Berger TG, Elston DM. Andrews’ diseases of the skin: clinical dermatology. 11th ed. Amsterdam: Saunders Elsevier; 2011. p. 448-51.
Handa H, Khare P, Sharva VA. A comprehensive review on pemphigus vulgaris. BJSTR. 2017 Nov 30;1(6):1796-9. doi: 10.26717/BJSTR.2017.01.000552.
Motghare VM, Bajait CJ, Turnakar A, Sontakke SD, Chavan S. Prescription pattern and adverse drug reaction profile of drugs prescribed in dermatology outpatient department at a tertiary care teaching hospital. Indian J Pharm Pharmacol. 2016 Oct-Dec;3(4):173-7.
Perwitasari DA, Urbayatun S. Treatment adherence and quality of life in diabetes mellitus patients in Indonesia. SAGE Open. 2016 Apr 28;26(2):6. doi: 10.1177/2158244016643748.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan 1;24(1):67-74. doi: 10.1097/00005650-198601000-00007, PMID 3945130.
World Health Organization Division of Mental Health and Prevention of Substance Abuse; 1998. Available from: https://www.google.com/search?q=World+Health+Organization+Division+of+Mental+Health+and+Prevention+of+Substance+Abuse.+1998 [Last accessed on 12 Feb 2024]
The use of the WHO-UMC system for standardised case causality assessment. Available from: https://www.who.int/publications/m/item/WHO-causality-assessment. [Last accessed on 12 Jan 2024]
Titou H, Pemphigus Vulgaris: A Clinical Study of 31 Cases (2004-2014) in Morocco. Dermatol Res Pract. 2020 Sep 8;2020. Doi: 10.1155/2020/8535109, PMID 32963520, PMCID: PMC7495221
Svecova D. Pemphigus vulgaris: a clinical study of 44 cases over a 20 y period. Int J Dermatol. 2015;54(10):1138-44. doi: 10.1111/ijd.12644, PMID 26394602.
Serwin AB, Koper M, Flisiak I. Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie province)-a 15 y (2001-2015) bicentric retrospective study. Int J Dermatol. 2018;57(8):933-7. doi: 10.1111/ijd.14078, PMID 29873080.
Mahajan VK, Sharma NL, Sharma RC, Garg G. Twelve-year clinical-therapeutic experience in pemphigus: a retrospective study of 54 cases. Int J Dermatol. 2005;44(10):821-7. doi: 10.1111/j.1365-4632.2005.02218.x, PMID 16207182.
Bastuji Garin S, Souissi R, Blum L, Turki H, Nouira R, Jomaa B. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol. 1995 Feb 1;104(2):302-5. doi: 10.1111/1523-1747.ep12612836, PMID 7829889.
Ishii N, Maeyama Y, Karashima T, Nakama T, Kusuhara M, Yasumoto S. A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11 y retrospective study (1996-2006). Clin Exp Dermatol. 2008 Sep 1;33(5):641-3. doi: 10.1111/j.1365-2230.2008.02881.x, PMID 18627388.
Heelan K, Mahar AL, Walsh S, Shear NH. Pemphigus and associated comorbidities: a cross-sectional study. Clin Exp Dermatol. 2015 Aug 1;40(6):593-9. doi: 10.1111/ced.12634, PMID 25786337.
Askın O, Ozkoca D, Kutlubay Z, Mat MC. A retrospective analysis of pemphigus vulgaris patients: demographics, diagnosis, co-morbid diseases and treatment modalities used. North Clin Istanb. 2020 Nov 20;7(6):597-602. doi: 10.14744/nci.2020.37039, PMID 33381700.
Uchmanowicz B, Chudiak A, Mazur G. The influence of quality of life on the level of adherence to therapeutic recommendations among elderly hypertensive patients. Patient Prefer Adherence. 2018 Dec 4;12:2593-603. doi: 10.2147/PPA.S182172, PMID 30584283.
Khayyat SM, Mohamed MMA, Khayyat SMS, Hyat Alhazmi RS, Korani MF, Allugmani EB. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey. Qual Life Res. 2019 Apr 1;28(4):1053-61. doi: 10.1007/s11136-018-2060-8, PMID 30470970.
Alsaqabi YS, Rabbani U. Medication adherence and its association with quality of life among hypertensive patients attending primary health care centers in Saudi Arabia. Cureus Inc. 2020(Dec 2);12(12):e11853. Doi: 10.7759/cureus.11853, PMID 33282607.
Published
How to Cite
Issue
Section
Copyright (c) 2024 RUHI TOMAR, SHIVANI YADAV, DUSHYANT K. CHAUHAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
